Antihyperglycaemic treatment of type 2 diabetes: results from a national diabetes register
- 30 September 2007
- journal article
- Published by Elsevier BV in Diabetes & Metabolism
- Vol. 33 (4), 269-276
- https://doi.org/10.1016/j.diabet.2007.02.003
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trialThe Lancet, 2005
- The gap between guidelines and reality: Type 2 diabetes in a national diabetes register 1996–2003Diabetic Medicine, 2005
- IFCC Reference System for Measurement of Hemoglobin A1c in Human Blood and the National Standardization Schemes in the United States, Japan, and Sweden: A Method-Comparison StudyClinical Chemistry, 2004
- European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)European Heart Journal, 2003
- Hypertension in diabetes: trends in clinical control in repeated large-scale national surveys from SwedenJournal of Human Hypertension, 2003
- UKPDS 60Stroke, 2002
- Sulfonylurea InadequacyDiabetes Care, 2002
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Diabetes Care and Research in Europe: The Saint Vincent DeclarationDiabetic Medicine, 1990